Outcome of Board Meeting

November 05, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Outcome of Board Meeting-November 05, 2026 Stock Code : BSE – 539787, NSE – HCG Reference : Regulation 30, 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) Further to our intimation dated October 13, 2026, and pursuant to Regulation 30, 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its meeting held on November 05, 2026, has, inter alia, considered and approved the Unaudited Financial Results of the Company (Standalone and Consolidated), for the quarter and six months ended September 30, 2026 (“Unaudited Financial Results”). In this regard, please find enclosed herewith the Unaudited Financial Results. The financial results are also being made available on the website of the Company and can be accessed at: https://www.hcgoncology.com/. The meeting of the Board of Directors commenced at 11.15 a.m. and concluded at 07.45 p.m. Kindly take the intimation on record and acknowledge receipt of the same. Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027 Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Emall-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Embassy Golf Links Business Park BS R & Co. LLP Pebble Beach, B Block, 3rd Floor No. 13/2, off Intermediate Ring Road Chartered Accountants Bengaluru -560 071, India Telephone: +91 80 4682 3000 Fax: +91 80 4682 3999 Limited Review Report on unaudited standalone financial results of HealthCare Global Enterprises Limited for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended To the Board of Directors of HealthCare Global Enterprises Limited 1. We have reviewed the accompanying Statement of unaudited standalone financial results of HealthCare Global Enterprises Limited (hereinafter referred to as "the Company") for the quarter ended 30 September 2026 and year to date results for the period from 1 April 2026 to 30 September 2026 ("the Statement"). 2. This Statement. which is the responsibility of the Company's management and approved by its Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ''Interim Financial Reporting' ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations"). Our responsibility is to issue a report on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SR E) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For B S R & Co. LLP Chartered Accountants Partner Bangalore Membership No.: 064597 05 November 2026 UDIN:26064597RPUTWH1754 Registered OHice.: B 5 R ~ Ca, (.a parlnershipfirmlh11h ~egi.s.Lra!ion Na. BA6:223) i=:anve-rt&d il'ltO BS R & Co LLP (a 14lh Flo£lr, Central B \Ning cincl North C 'Aring, Nesco IT Palk 4, Nesco Limi1ad Liability Partnorsb1p\V:th LLP R:egislrc1taon No. AAB-i:1181) with effect from Oi:;tober 14. 2013 Center. ~'le~tem Express Highway, Goregaon (Eas1}, Mumb.-i -40006:, Page 1 of 1 HealthCare Global Enterprises Limited CIN : L15200KA1998PLC023489 Regd. Office: HCG Tower, No. 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bengaluru 560 027, Karnataka, India Corp. Office: Tower Block, Unity Building Complex, No. 3, Mission Road, Bengaluru 560 027, Karnataka, India STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED AND SIX MONTHS ENDED 30 SEPTEMBER 2026 (Rs. in Lakhs except share data) Quarter Preceding quarter Corresponding Six months Six months Previous year SI. ended ended quarter ended ended ended ended Particulars No. 30 September 2026 30 June 2026 30 September 2025 30 September 2026 30 September 2025 31 March 2026 Unaudited Unaudited Unaudited Unaudited Unaudited Audited I Income (a) Revenue from operations 39,604 37,525 34,441 77,129 67,034 135,937 (b) Income from government grant 136 141 143 277 259 593 ( c) Other income 395 956 382 1,351 1,176 2,967 Total income 40,135 38,622 34,966 78,757 68,469 139,497 2 Expenses (a) Purchases of medical and non-medical items 9,611 9,561 9,077 19,172 17,501 35,864 (b) Changes in inventories 333 (360) (140) (27) (501) (548) (c) Employee benefits expense 7,007 5,967 5,286 12,974 10,927 21,192 (d) Finance costs 2,225 2,173 2,136 4,398 4,566 8,646 ( e) Depreciation and amortisation expense 3,574 3,957 3,016 7,531 5,841 1 J,980 (t) Medical consultancy charges 8,083 7,734 6,563 15,817 12,991 26,343 (g) Other expenses 8,934 8,842 7,568 17,776 15,160 29,520 Total expenses 39,767 37,874 33,506 77,641 66,485 132,997 3 Profit before exceptional items and tax (1-2) 368 748 1,460 1,116 1,984 6,500 4 Exceptional items (refer note 2) (661) - - (661) - (5,538) 5 Profit /(loss) before tax (3+4) (293) 748 1,460 455 1,984 962 6 Tax expense -Current tax (refer note 6) 27 362 438 389 772 404 -Deferred tax {116) (172) (56) (288) (211) (900) Total tax expense (89) 190 382 101 561 (496) 7 Profit / (loss) for the period /year (5-6) (204) 558 1,078 354 1,423 1,458 8 Other comprehensive income/ (loss) Items that will not be reclassified subsequently to profit or loss -Remeasurements of the defined benefit plans (83) - ( 15) (83) (15) 11 -Jncome tax effect on above 21 - 4 21 4 (3) Other comprehensive income/ (loss) for the period / year, (62) - (11) (62) (11) 8 net of tax 9 Total comprehensive income (loss) for the period/ year (266) 558 1,067 292 1,412 1,466 (7+8) 10 Paid-up equity share capital (Face value of Rs. JO each) 14,930 14,930 14,100 14,930 14,100 14,930 11 Reserves, i [Showing first 8,000 characters — download PDF for full document]